Cargando…

Patient, Diagnosis, and Treatment Delays Among Tuberculosis Patients Before and During COVID-19 Epidemic — China, 2018–2022

WHAT IS ALREADY KNOWN ABOUT THIS TOPIC? The coronavirus disease (COVID-19) pandemic could have a damaging impact on access to tuberculosis (TB) diagnosis and treatment. WHAT IS ADDED BY THIS REPORT? The overall delay experienced by TB patients during the COVID-19 pandemic has shown a modest decrease...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Tao, Du, Xin, Kang, Jiaojie, Luo, Dan, Liu, Xiaoqiu, Zhao, Yanlin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2023
Materias:	Preplanned Studies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150750/ https://www.ncbi.nlm.nih.gov/pubmed/37138894 http://dx.doi.org/10.46234/ccdcw2023.047

Ejemplares similares

Implementation Performance of Tuberculosis Control in China: 2011–2020
por: Li, Tao, et al.
Publicado: (2021)

Health Facilities and Treatment Service Models of the National Tuberculosis Program — China, 2010−2020
por: Du, Xin, et al.
Publicado: (2021)

Age-Specific Pulmonary Tuberculosis Notification Rates — China, 2008–2018
por: Li, Tao, et al.
Publicado: (2022)

Impact of Whole Lung Lavage on Pneumoconiosis Patients — China, 2018–2022
por: Chen, Yun, et al.
Publicado: (2023)

Financial Burden of Tuberculosis Patients — China, 2020
por: Xu, Caihong, et al.
Publicado: (2023)

Predictors for Treatment Outcomes in Patients with Multi-drug Resistant Tuberculosis — China, 2018–2020
por: Zhang, Shunxian, et al.
Publicado: (2022)

Malaria Diagnosis and Verification — China, 2017–2018
por: Yin, Jianhai, et al.
Publicado: (2020)

Effectiveness of the Integrated TB Surveillance System — China, 2018–2019
por: Wang, Ni, et al.
Publicado: (2020)

Underreporting of Notifiable Pulmonary Tuberculosis Cases to the National Tuberculosis Information Management System — China, 2015
por: Li, Tao, et al.
Publicado: (2020)

The Impact of COVID-19 on Tuberculosis Patients’ Behavior of Seeking Medical Care — China, 2020
por: Xia, Yinyin, et al.
Publicado: (2021)

Occurrence and Removal of Antibiotic Resistance in Nationwide Hospital Wastewater Deciphered by Metagenomics Approach — China, 2018–2022
por: Huang, Jin, et al.
Publicado: (2023)

A Questionnaire Survey on Extrapulmonary Tuberculosis Control and Prevention — China, 2021
por: Wang, Mingzhe, et al.
Publicado: (2023)

The Impact of COVID-19 Epidemic on Tuberculosis Reports Among Students — Guizhou Province, China, 2020
por: He, Yuying, et al.
Publicado: (2022)

Characteristics of Injury Diagnosis among Primary and Secondary School Students — China, 2018
por: Ye, Pengpeng, et al.
Publicado: (2020)

Predicted Impact of the COVID-19 Responses on Deaths of Tuberculosis — China, 2020
por: Xu, Caihong, et al.
Publicado: (2021)

Mushroom Poisoning Outbreaks — China, 2022
por: Li, Haijiao, et al.
Publicado: (2023)

Characteristics of Lung Function and Prevalence of Airflow Obstruction Among Individuals Aged 18–74 Years — Beijing, China, 2017–2018
por: Wang, Jiamin, et al.
Publicado: (2022)

Attitudes Regarding Influenza Vaccination Among Public Health Workers during COVID-19 Pandemic — China, September 2022
por: Yi, Heya, et al.
Publicado: (2023)

Changing Mortality and Patterns of Death Causes in HIV Infected Patients — China, 2013–2022
por: Zhao, Yan, et al.
Publicado: (2023)

Disproportionate Increase of New Diagnosis of HIV/AIDS Infection by Sex and Age — China, 2007−2018
por: Zhang, Yewu, et al.
Publicado: (2020)

Soil-Transmitted Helminthiasis — China, 2018
por: Zhu, Huihui, et al.
Publicado: (2020)

Trends in Adult Cooking Salt Intake — China, 1991−2018
por: Zhang, Jiguo, et al.
Publicado: (2020)

Epidemic Features of COVID-19 and Potential Impact of Hospital Strain During the Omicron Wave — Australia, 2022
por: Yang, Jingli, et al.
Publicado: (2023)

Distribution of Triatomines, the Vector of Chagas Disease — Southern China, 2016−2018
por: Liu, Qin, et al.
Publicado: (2020)

Prevalence of Metabolic Syndrome and Risk Factors Among Chinese Adults: Results from a Population-Based Study — Beijing, China, 2017–2018
por: Liu, Jufen, et al.
Publicado: (2022)

National Proficiency Testing of Molecular Diagnostics for Tuberculosis and Drug Resistance Detection — China, 2014–2019
por: Ou, Xichao, et al.
Publicado: (2021)

Association of COVID-19 Vaccination and Clinical Severity of Patients Infected with Delta or Omicron Variants — China, May 21, 2021–February 28, 2022
por: Li, Mingshuang, et al.
Publicado: (2022)

Survey on Immunization Services for Children with Medical Conditions — China, 2022
por: Huang, Yong, et al.
Publicado: (2023)

The Infection of Healthcare Workers and the Reinfection of Patients by Omicron Variant — Jiangsu Province, China, December 2022 to January 2023
por: Zhang, Chuanmeng, et al.
Publicado: (2023)

Increased Incidence of Scarlet Fever — China, 1999−2018
por: You, Yuanhai, et al.
Publicado: (2019)

Characteristics of Falls Among Older People — China, 2018
por: Lu, Zhiming, et al.
Publicado: (2021)

Cervical Cancer Screening Coverage — China, 2018–2019
por: Zhang, Mei, et al.
Publicado: (2022)

Breast Cancer Screening Coverage — China, 2018–2019
por: Zhang, Mei, et al.
Publicado: (2023)

Prevalence and Types of Comorbidities in Pneumoconiosis — China, 2018–2021
por: Wang, Huanqiang, et al.
Publicado: (2023)

Epidemiological and Clinical Features of Patients with Scrub Typhus — Guangzhou City, Guangdong Province, China, 2012–2018
por: Wei, Yuehong, et al.
Publicado: (2021)

Assessment of the Health-Related Quality of Life in Neurocysticercosis Patients in Hot Spot Areas — China, 2017–2018
por: Qian, Yingjun, et al.
Publicado: (2022)

COVID-19 Stay-At-Home Orders and Older Adults’ Cognitive Health — United States, June 2018–February 2022
por: Choi, Nam Sun, et al.
Publicado: (2022)

COVID-19 Mortality and Vaccine Coverage — Hong Kong Special Administrative Region, China, January 6, 2022–March 21, 2022
por: Smith, Dallas J., et al.
Publicado: (2022)

Hesitancy to Receive the Booster Doses of COVID-19 Vaccine Among Cancer Patients in China: A Multicenter Cross-Sectional Survey — Four PLADs, China, 2022
por: Wang, Yuxiao, et al.
Publicado: (2023)

Investigation on Work-Related Musculoskeletal Disorders — China, 2018−2019
por: Jia, Ning, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b9pg4j76o29ac8al0sv6sks89c